Comparison of the Complications in Multiple Myeloma Patients Who Received Autologous Stem Cell Transplantation Between in HEPA-filtered Room and Non-HEPA-filtered Room
Not yet recruiting
- Conditions
- Multiple Myeloma
- Registration Number
- NCT06286241
- Lead Sponsor
- Siriraj Hospital
- Brief Summary
The goal of this observational study is to comparison of the complications in multiple myeloma patients who received autologous stem cell transplantation between in HEPA-filtered room and non-HEPA-filtered room. The main questions it aims to answer are:
* The incidence of febrile neutropenia, infection, and duration of hospital stay
* 2-year progression free survival Participants will be collected the data of baseline diagnosis, treatment, treatment results and complications during admission and follow-up visits from hospital medical record.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 344
Inclusion Criteria
- aged 18 - 65 years old
- Patients with multiple myeloma undergoing treatment with autologous stem cell transplantation and having a Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) score less than or equal to 2
- Patients must provide signed consent to participate in the research if they undergo ASCT after the study has been approved.
- If patients undergo ASCT before the study approval, retrospective data will be collected.
Exclusion Criteria
- Patients with concomitant other types of cancer
- Patients who refuse to participate in the study.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method progression free survival 2 years duration of survival
febrile neutropenia during admission incidence of febrile neutropenia
Infection during admission incidence of Infection
duration of admission during admission duration of admission
- Secondary Outcome Measures
Name Time Method